Gabapentin enacarbil (Horizant (in USA) Regnite (in Japan) formerly known as XP-13512) is a prodrug for the anticonvulsant and analgesic drug gabapentin. It was designed for increased oral bioavailability over gabapentin and human trials showed it to produce extended release of gabapentin with almost twice the overall bioavailability especially when taken with a fatty meal.
This page contains content from the copyrighted Wikipedia article "Gabapentin enacarbil"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
